1. Home
  2. WLDN vs VIR Comparison

WLDN vs VIR Comparison

Compare WLDN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willdan Group Inc.

WLDN

Willdan Group Inc.

HOLD

Current Price

$87.00

Market Cap

1.3B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$11.09

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDN
VIR
Founded
1964
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
WLDN
VIR
Price
$87.00
$11.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$114.50
$19.43
AVG Volume (30 Days)
201.9K
1.8M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
120.89
17.49
EPS
2.13
N/A
Revenue
$273,352,000.00
$68,556,000.00
Revenue This Year
N/A
$270.22
Revenue Next Year
$12.05
N/A
P/E Ratio
$40.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$64.67
$4.75
52 Week High
$137.00
$11.94

Technical Indicators

Market Signals
Indicator
WLDN
VIR
Relative Strength Index (RSI) 59.41 61.65
Support Level $72.52 $8.43
Resistance Level $88.72 $11.66
Average True Range (ATR) 2.85 0.67
MACD -0.15 0.10
Stochastic Oscillator 74.81 73.41

Price Performance

Historical Comparison
WLDN
VIR

About WLDN Willdan Group Inc.

Willdan Group Inc is a technical services company focused on energy and infrastructure solutions. The company's solutions include energy planning and analytics, consulting, software, public finance, engineering, and program implementation. It operates through two segments: i) Energy segment: It provides specialized, comprehensive energy solutions to businesses, utilities, state agencies, municipalities, and non-profit organizations. ii) Engineering & Consulting: It provides civil engineering and construction management, building and safety services, city engineering and planning support, civil design, geotechnical services, and material testing. The majority of revenue is derived from the Energy segment. Geographically, all of the company's revenue is generated from the United States.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: